Drugs · acquisition-cost intelligence
Senokot
standardized senna concentrate· ingredient sennosides, USP· SENNOSIDES 17.2 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.41634
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 5 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sennosides, USP products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| CAREALL Sennosides | $0.02526 | −$0.39110 |
| Colace | $0.03053 | −$0.38580 |
| GeriCare Senna Syrup | $0.04200 | −$0.37430 |
| EX-LAX REGULAR STRENGTH STIMULANT LAXATIVE | $0.06732 | −$0.34900 |
| Chocolated Laxative | $0.10625 | −$0.31010 |
| HEB Maximum strength Laxative pills | $0.11625 | −$0.30010 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.